ArticleDrug design, development and therapy2022

Preclinical Pharmacokinetics, Tissue Distribution and in vitro Metabolism of FHND6091, a Novel Oral Proteasome Inhibitor.

Xu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.